HomeTagsMedical

medical

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

Why China Medical Systems FY2025 Profits Dropped Despite Growth

https://open.spotify.com/episode/3YAldvdzS4eXE4RzkN9M18?si=8a54594510534cfe 5 Game-Changing Takeaways from CMS’s 2025 Transformation For the Chinese pharmaceutical sector, 2025 was the...
SGX-LISTED COMPANIES

Why Q & M Dental Is Aggressively Expanding Despite A 35% Bottom-Line Dip In FY2025

https://open.spotify.com/episode/0T0lgGE0YOpVf9BPYLy2w2?si=dfeecf16edc8405e A New Era for Regional Healthcare For the discerning financial analyst, Q & M Dental...
SGX-LISTED COMPANIES

How Raffles Medical Is Trading Episodic Care For Longevity Science In FY2025

Introduction: A Half-Century of Evolution As Raffles Medical Group (RMG) marks its 50th anniversary, it...
SGX-LISTED COMPANIES

How HC Surgical Specialists Boosted Profits Despite A Revenue Dip In HY FY2026

Precision in the Markets In the business of medicine, conventional wisdom suggests that if your...
SGX-LISTED COMPANIES

Top Glove 1QFY2026 Profits Explode By 680%

Top Glove’s Profits Soared 680% on Flat Revenue. Here’s How. Introduction: The global glove industry has...
SGX-LISTED COMPANIES

Singapore Paincare Swings To Net Loss In FY2025

5 Surprising Reasons Behind Singapore Paincare's Shocking Swing from Profit to a S$3.7 Million...
SGX-LISTED COMPANIES

Find Out Why ISEC Healthcare’s Strong Q3 2025 Sales Didn’t Translate To Higher Profits

More Sales, Less Profit: 5 Surprising Takeaways from ISEC Healthcare's Latest Financials It’s a fundamental...
SGX-LISTED COMPANIES

Thomson Medical Group’s FY2025: Strategic Growth and Johor Bay Development

Thomson Medical Group's recent financial period reflects a deliberate investment strategy for future growth,...

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...